Sun Pharma to acquire Organon in an all-cash transaction worth $11.75 billion Enterprise Value
India’s largest drugmaker, Sun Pharmaceuticals Ltd., has announced on Monday, April 27, that it has signed a definitive agreement to acquire US-listed Organon for sustained, long-term value creation and complementary portfolios that will enhance its business leverage. Sun Pharma will acquire 100% of Organon’s outstanding equity at an enterprise value of $11.75 billion, it said…
